Emmanuelle Charpentier studied biochemistry and microbiology at the University Pierre and Marie Curie, Paris, France where she received her PhD in Microbiology for her research performed at the Pasteur Institute. She then moved to the United States, where she held Research Associate positions at the Rockefeller University, New York University Langone Medical Center and the Skirball Institute of Biomolecular Medicine (all in New York, NY) and at St Jude Children’s Research Hospital (in Memphis, TN). Emmanuelle Charpentier returned to Europe to establish her own research group at the Max F. Perutz Laboratories of the University of Vienna in Austria where she habilitated in the field of Microbiology. She was then recruited as an Associate Professor at the Laboratory for Molecular Infection Medicine Sweden (MIMS, Swedish Node of the European Molecular Biology Laboratory (EMBL) Partnership for Molecular Medicine) at Umeå University. In 2012 Emmanuelle Charpentier was appointed Professor at Hannover Medical School (MHH) and head of the department “Regulation in Infection Biology” at the HZI. In 2013, Emmanuelle was awarded an Alexander von Humboldt Professorship. In 2015, Emmanuelle was appointed Scientific Member of the Max Planck Society and Director of the Department of Regulation in Infection Biology at the Max Planck Institute for Infection Biology in Berlin, Germany. Together with Jennifer Doudna she was awarded the Nobel Prize in Chemistry in 2020.
Max Planck Institute for Infection Biology